Stock ELOX ELOXX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Market Closed - OTC Markets
Other stock markets
 14:36:12 2024-06-27 EDT 		5-day change 1st Jan Change
0.69 USD 0.00% Intraday chart for Eloxx Pharmaceuticals, Inc. +0.03% -42.50%
04-11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
03-13 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Eloxx Pharmaceuticals, Inc. Announces Resignation of Tomer Kariv from the Board
CI
Eloxx Pharmaceuticals, Inc. Announces Resignation of Vijay Modur as Head of Research and Development
CI
Eloxx Pharmaceuticals, Inc. Announces Committee Changes
CI
Eloxx Pharmaceuticals Announces Changes to Board of Directors
CI
Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer
CI
Eloxx Pharmaceuticals, Inc. Appoints Ali Hariri as Chief Medical Officer
CI
Eloxx Pharmaceuticals, Inc. Appoints Daniel Geffken as Principal Accounting Officer
CI
Gary Rakers to Resign as Executive Director, Finance & Accounting, Corporate Conroller and Treasurer of Eloxx Pharmaceuticals, Inc, Effective July 30, 2021
CI
Eloxx Pharmaceuticals, Inc. Announces the departure of Neil Belloff as Chief Operating Officer and General Counsel, Effective August 25, 2021
CI
Eloxx Pharmaceuticals, Inc. Announces Executive Changes
CI
Eloxx Pharmaceuticals, Inc. Announces Change of CEO
CI
Eloxx Pharmaceuticals, Inc. Appoints Daniel Geffken as Interim Chief Financial Officer
CI
Eloxx Pharmaceuticals, Inc. Announces Board Changes
CI
Eloxx Pharmaceuticals, Inc. Announces Resignation of Stephen Macdonald as Vice President, Finance and Accounting, and Treasurer (Principal Financial and Accounting Officer) Effective March 26, 2021
CI
Eloxx Pharmaceuticals, Inc. Announces Appointment of Eitan Kerem as Senior Consultant
CI
Eloxx Pharmaceuticals, Inc. Announces Executive Changes; Announces Organizational Re-Alignment
CI
Eloxx Pharmaceuticals, Inc. Hires Susan Schneider as Senior Vice President Ophthalmology
CI
Pedro Huertas Intention to Resign as Chief Medical Officer of Eloxx Pharmaceuticals, Inc
CI
Eloxx Pharmaceuticals, Inc. Announces Executive Appointments
CI
Eloxx Pharmaceuticals, Inc. Appoints Neil Belloff as Executive Vice President, General Counsel and Corporate Secretary
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELOX Stock
  4. News Eloxx Pharmaceuticals, Inc.
  5. Insiders